Beyond LDL: Understanding Triglyceride-Rich Lipoproteins to Tackle Residual Risk

Abstract

For the past 30 years, statin therapy has been the cornerstone for the reduction in the risk of atherosclerotic cardiovascular disease (ASCVD) [...]

Keywords

• n/a